Gelteq is trading at $0.45, down 8.09%, with no confirmed company-specific catalyst identified. - A November 2 filing notification said Gelteq needs more time to finalize its annual report and expects to file within the permitted 15-day grace period. - The notice provided no preliminary financial figures and cited no specific cause for the delay. - The supplied sector update reported XBI down 2.39% during the regular session amid broad risk-off sentiment. This is relevant context but does not establish the direct cause of Gelteq’s decline.